| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,638 |
3,262 |
$230K |
| 78492 |
|
791 |
660 |
$194K |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
896 |
679 |
$186K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,184 |
1,053 |
$175K |
| 93975 |
|
291 |
266 |
$76K |
| 99215 |
Prolong outpt/office vis |
765 |
629 |
$52K |
| 93880 |
|
327 |
304 |
$41K |
| 93015 |
|
788 |
659 |
$36K |
| 76770 |
|
260 |
254 |
$30K |
| 93970 |
|
212 |
206 |
$29K |
| 93925 |
|
161 |
154 |
$28K |
| J2785 |
Injection, regadenoson, 0.1 mg |
162 |
148 |
$27K |
| 93978 |
|
164 |
155 |
$25K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
226 |
216 |
$21K |
| 93224 |
|
368 |
305 |
$21K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
223 |
190 |
$19K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
398 |
347 |
$14K |
| 93229 |
|
27 |
27 |
$14K |
| 99205 |
Prolong outpt/office vis |
88 |
77 |
$12K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
194 |
175 |
$8K |
| 93922 |
|
117 |
114 |
$8K |
| 93040 |
|
456 |
365 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
318 |
196 |
$3K |
| 94729 |
|
72 |
68 |
$2K |
| 94726 |
|
70 |
67 |
$2K |
| 93000 |
|
172 |
160 |
$2K |
| 94010 |
|
103 |
84 |
$1K |
| 94200 |
|
72 |
68 |
$934.61 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
86 |
61 |
$805.56 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
13 |
$773.52 |
| 93228 |
|
27 |
27 |
$536.87 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
58 |
44 |
$83.72 |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
26 |
25 |
$61.09 |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
289 |
209 |
$0.00 |